NCX-701 (NicOx)

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

NicOx is developing NCX-701, a nitric oxide-releasing derivative of paracetamol (acetaminophen), for the potential treatment of inflammation and pain. The compound is currently undergoing phase III clinical trials.

Original languageEnglish (US)
Pages (from-to)755-759
Number of pages5
JournalCurrent Opinion in Investigational Drugs
Volume5
Issue number7
StatePublished - Jul 1 2004

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'NCX-701 (NicOx)'. Together they form a unique fingerprint.

  • Cite this